Lukas Scheibler is Chief Research Officer of Apellis Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Apellis Pharmaceuticals, Inc.
5 Dec 23
144
Apellis Pharmaceuticals, Inc.
1 Dec 23
4
Apellis Pharmaceuticals, Inc.
7 Sep 23
144
Apellis Pharmaceuticals, Inc.
6 Sep 23
4
Apellis Pharmaceuticals, Inc.
22 Feb 23
4
Apellis Pharmaceuticals, Inc.
14 Feb 23
4
Apellis Pharmaceuticals, Inc.
30 Jan 23
4
Apellis Pharmaceuticals, Inc.
24 Jan 23
4
Apellis Pharmaceuticals, Inc.
17 Jan 23
4
Apellis Pharmaceuticals, Inc.
31 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Dec 23 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 60 | 10,000 | 600.00 k | 68,299 |
1 Dec 23 | APLS Apellis Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | Yes | 13.85 | 10,000 | 138.50 k | 78,299 |
1 Dec 23 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 13.85 | 10,000 | 138.50 k | 39,391 |
6 Sep 23 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 43.01 | 1,756 | 75.53 k | 68,299 |
21 Feb 23 | APLS Apellis Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 58.5 | 715 | 41.83 k | 69,643 |
21 Feb 23 | APLS Apellis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 9,886 | 0.00 | 70,358 |
21 Feb 23 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 35.46 | 14,023 | 497.26 k | 14,023 |
10 Feb 23 | APLS Apellis Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 51.21 | 678 | 34.72 k | 60,472 |
27 Jan 23 | APLS Apellis Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 52.77 | 542 | 28.60 k | 61,150 |